PIR
Pirin
Also known as: PIR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00625
- Gene
- PIR
- Ensembl
- ENSG00000087842
- Chromosome
- X
- Canonical length
- 290 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
This gene encodes a member of the cupin superfamily. The encoded protein is an Fe(II)-containing nuclear protein expressed in all tissues of the body and concentrated within dot-like subnuclear structures. Interactions with nuclear factor I/CCAAT box transcription factor as well as B cell lymphoma 3-encoded oncoprotein suggest the encoded protein may act as a transcriptional cofactor and be involved in the regulation of DNA transcription and replication. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
290 residues, UniProt reviewed canonical sequence.
>O00625|PIR
1 MGSSKKVTLS VLSREQSEGV GARVRRSIGR PELKNLDPFL LFDEFKGGRP GGFPDHPHRG
61 FETVSYLLEG GSMAHEDFCG HTGKMNPGDL QWMTAGRGIL HAEMPCSEEP AHGLQLWVNL
121 RSSEKMVEPQ YQELKSEEIP KPSKDGVTVA VISGEALGIK SKVYTRTPTL YLDFKLDPGA
181 KHSQPIPKGW TSFIYTISGD VYIGPDDAQQ KIEPHHTAVL GEGDSVQVEN KDPKRSHFVL
241 IAGEPLREPV IQHGPFVMNT NEEISQAILD FRNAKNGFER AKTWKSKIGNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 37 nTPM
- choroid plexus: 33 nTPM
- urinary bladder: 32 nTPM
- midbrain: 31 nTPM
- esophagus: 28 nTPM
- basal ganglia: 25 nTPM
Single-cell type
- myonuclei: 224 nCPM
- melanocytes: 202 nCPM
- urothelial cells: 184 nCPM
- cytotrophoblasts: 171 nCPM
- retinal ganglion cells: 143 nCPM
- syncytiotrophoblasts: 132 nCPM
Immune cell
- T-reg: 0.3 nTPM
- eosinophil: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- white matter: 26 nTPM
- cerebellum: 22 nTPM
- basal ganglia: 22 nTPM
- medulla oblongata: 21 nTPM
- hypothalamus: 21 nTPM
- midbrain: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.8
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.4
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- metal ion binding
- transcription coregulator activity
- quercetin 2,3-dioxygenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RmlC-like cupin domain superfamily
- RmlC-like jelly roll fold
- Pirin, N-terminal domain
- Pirin, C-terminal domain
- Pirin
- Pirin
- Pirin C-terminal cupin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PIR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIR as an antibody target. Whether an autoantibody or antibody against PIR could matter depends on whether native PIR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PIR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...